We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+9.35%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$7.44B
AUM Growth
+$332M
Cap. Flow
-$154M
Cap. Flow %
-2.07%
Top 10 Hldgs %
30.42%
Holding
323
New
41
Increased
71
Reduced
173
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 24.38%
2 Consumer Discretionary 19.67%
3 Communication Services 16.92%
4 Healthcare 14.22%
5 Miscellaneous 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UI icon
251
Ubiquiti
UI
$34.1B
$112K ﹤0.01%
1,582
-1,593
-50% -$102K
ESPR
252
DELISTED
Esperion Therapeutics
ESPR
$111K ﹤0.01%
1,689
SIRI icon
253
SiriusXM
SIRI
$9.95B
$101K ﹤0.01%
1,883
+96
+5% +$5.3K
HRI icon
254
Herc Holdings
HRI
$4.65B
$94K ﹤0.01%
1,507
-512
-25% -$28.2K
UNH icon
255
UnitedHealth
UNH
$337B
$87K ﹤0.01%
+396
New +$83.9K
NBLX
256
DELISTED
Noble Midstream Partners LP
NBLX
$60K ﹤0.01%
1,207
-51
-4% -$2.58K
NPTN
257
DELISTED
NEOPHOTONICS CORP
NPTN
$59K ﹤0.01%
8,963
BRK.B icon
258
Berkshire Hathaway Class B
BRK.B
$1.11T
$43K ﹤0.01%
218
+18
+9% +$3.42K
BMA icon
259
Banco Macro
BMA
$4.86B
$37K ﹤0.01%
315
-489
-61% -$57.3K
STDY
260
DELISTED
SteadyMed Ltd
STDY
$31K ﹤0.01%
8,512
-12,984
-60% -$41.9K
PACB icon
261
Pacific Biosciences
PACB
$417M
$23K ﹤0.01%
8,659
-14,372
-62% -$50.3K
DE icon
262
Deere & Co
DE
$184B
$16K ﹤0.01%
100
VYGR icon
263
Voyager Therapeutics
VYGR
$190M
$15K ﹤0.01%
877
-1,340
-60% -$23K
ACHC icon
264
Acadia Healthcare
ACHC
$2.55B
-130,392
Closed -$6.23M
ALTO icon
265
Alto Ingredients
ALTO
$317M
-2,215
Closed -$12K
ATKR icon
266
Atkore
ATKR
$3.19B
-16,905
Closed -$330K
CCOI icon
267
Cogent Communications
CCOI
$473M
-7,152
Closed -$350K
EXPE icon
268
Expedia Group
EXPE
$35.2B
-37,116
Closed -$5.34M
HCC icon
269
Warrior Met Coal
HCC
$4.84B
-8,674
Closed -$204K
ITUB icon
270
Itaú Unibanco
ITUB
$91B
-513,176
Closed -$3.41M
NCLH icon
271
Norwegian Cruise Line
NCLH
$6.56B
-12,535
Closed -$678K
NVAX icon
272
Novavax
NVAX
$1.52B
-1,791
Closed -$41K
PCRX icon
273
Pacira BioSciences
PCRX
$960M
-217,091
Closed -$8.15M
RNR icon
274
RenaissanceRe
RNR
$13.7B
-167
Closed -$23K
SND icon
275
Smart Sand
SND
$219M
-398,633
Closed -$2.7M

Similar funds

Gilder Gagnon Howe & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Gilder Gagnon Howe & Co held 323 positions worth $7.44B, up 4.7% from $7.11B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gilder Gagnon Howe & Co's Q4 2017 filing shows 41 new, 71 increased, 173 reduced and 29 closed positions. Its largest new stake was Sony: 9,796,230 shares worth $88.1M. The largest sale was Amazon, an estimated $132M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Gilder Gagnon Howe & Co's largest Q4 2017 buy was Sony: 9,796,230 shares worth $88.1M.
  • Gilder Gagnon Howe & Co added most to T-Mobile US in Q4 2017, an estimated $49.6M increase.
  • Gilder Gagnon Howe & Co's biggest Q4 2017 reduction was Amazon, cutting an estimated $132M.
  • Gilder Gagnon Howe & Co fully exited Gigamon Inc. in Q4 2017, selling an estimated $38.6M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 30% of its $7.44B portfolio in Q4 2017.
  • Gilder Gagnon Howe & Co opened 41 new positions and closed 29 in Q4 2017.
  • Gilder Gagnon Howe & Co's portfolio value rose 4.7% quarter-over-quarter to $7.44B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2017, filed 31 Jan 2018.